Drug Shortage Report for TEVA-ALENDRONATE/CHOLECALCIFEROL

Last updated on 2018-12-21 History
Report ID 23143
Drug Identification Number 02403633
Brand name TEVA-ALENDRONATE/CHOLECALCIFEROL
Common or Proper name ALENDRONATE VIT D
Company Name TEVA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) ALENDRONIC ACID VITAMIN D3
Strength(s) 70MG 2800UNIT
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 4
ATC code M05BB
ATC description DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2017-10-30
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-12-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-09-22 English Compare
v2 2017-09-22 French Compare
v3 2017-10-31 English Compare
v4 2017-11-06 English Compare
v5 2017-11-06 French Compare
v6 2018-02-21 English Compare
v7 2018-02-21 French Compare
v8 2018-05-30 English Compare
v9 2018-05-30 French Compare
v10 2018-10-11 English Compare
v11 2018-10-11 French Compare

Showing 1 to 11 of 11